Physician
Western Oklahoma Pain Specialists LLC
Western Oklahoma Pain Specialists LLC was paid $2.50M by Medicaid between Aug 2019 and Nov 2024, across 27 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 65% of everything it billed.
33Billing provider infoWESTERN OKLAHOMA PAIN SPECIALISTS LLC
ELK CITY, OK 73644
ELK CITY, OK 73644
33aNPI1558885749assigned 07/28/2017
33bProvider typeInterventional Pain Medicine Physician
28Total paid$2.50M
24GClaims56,737
24DCodes billed27
24AFirst – last monthAug 2019 – Nov 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Oklahoma
Rank by total paid#2 of 10
Median peer was paid$101K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 83 | $6K | |
| 2021 | 2,190 | $101K | |
| 2022 | 12,508 | $584K | |
| 2023 | 12,657 | $594K | |
| 2024incomplete | 29,299 | $1.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 65% | 22,052 | 21,654 | $1.64M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 28% | 12,737 | 12,551 | $694K |
| 62323 | 2.0% | 368 | 365 | $49K | |
| 96132 | 1.1% | 393 | 393 | $27K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.0% | 246 | 246 | $25K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 81 | 81 | $14K |
| 01992 | <1% | 111 | 105 | $13K | |
| 96138 | <1% | 418 | 418 | $7K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 65 | 65 | $6K |
| 64493 | <1% | 40 | 40 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 789 | 784 | $5K |
| 80305 | <1% | 256 | 254 | $3K |
15 more codes
| 64494 | <1% | 27 | $2K | |
| 62321 | <1% | 12 | $2K | |
| 99406 | <1% | 143 | $2K | |
| 27096 | <1% | 14 | $2K | |
| 64451 | <1% | 12 | $2K | |
| 99152 | <1% | 118 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 20 | $1K |
| 96127 | <1% | 180 | $699.78 | |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | <1% | 303 | $698.20 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 40 | $401.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 296 | $316.32 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 14,139 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,394 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 150 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 333 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBLICK, BRIAN (PHYSICIAN/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Western Oklahoma Anesthesia Consultants PLLC | Elk City, OK | $20K |
| Blick Medical LLC | Elk City, OK | $3K |
| West Texas Pain Specialists, LLC | Pampa, TX | $337.69 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.